drugset / Trial / NCT00003433
Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer
Treatment
Summary
RATIONALE: Immunotherapy using CEA-treated white blood cells may help a person's body build an immune response to kill their tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of immunotherapy with CEA-treated white blood cells in treating patients with resected liver metastases from colon cancer.
Timeline
- Start
- 1998-06
- Primary completion
- —
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | carcinoembryonic antigen RNA-pulsed DC cancer vaccine | Cell therapy | — | Intravenous |